With regard to NASH parameters, AST (27.7 IU/L vs. 16.5 IU/L; p = 0.0145), ALT (29.2 IU/L vs. 15.4 IU/L; p = 0.0004), MDA-LDL (123.2 U/L vs. 96.9 U/L; p = 0.0032), and liver volume (1921.7 mL vs. 1551.9 mL; p = 0.0071) were significant factors (Table 4). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.